Patent · US Active

Injectable formulations for organ augmentation

US9724367B2 · kind B2 · utility

3Cited by

35References

47Claims

0Family size

Assignee

RegenMed (Cayman) LTD. · KY

Inventors

Joydeep Basu · Winston-Salem, US
Richard Payne · Winston-Salem, US
Neil F. Robbins · Cary, US
Oluwatoyin A. Knight · Winston-Salem, US
Deepak Jain · Garland, US
Craig R. Halberstadt · Charlotte, US
Monica A. Serban · Melrose, US

Key dates

Filing date	Nov 10, 2011
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Jun 3, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns phase changing injectable formulations for organ augmentation containing active agents, such as bioactive cell populations, and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.